期刊文献+

3-三氟甲基苯甲酰胺类衍生物对H5N1流感病毒进入靶细胞的抑制活性 被引量:2

Inhibitory activities of 3- trifluoromethyl benzamide derivatives against the entry of H5N1 influenza viruses
下载PDF
导出
摘要 目的 3-三氟甲基苯甲酰胺类衍生物作为新的抗流感药物能否抑制H5N1流感病毒进入靶细胞。方法对先导化合物进行改构,发现并合成具有进入抑制活性的3个化合物,同时从Specs公司化合物库挑选购买了一些化合物,同样发现了4个有抑制活性的化合物,利用建立在细胞水平的H5N1假病毒活性检测方法测试了这些化合物的抑制活性。结果和结论化合物1a,1b,1e和1f对源自A/AnHui/1/2005的H5N1假病毒毒株有明显的抑制作用。化合物1a的活性最好,其IC50达到4.7±0.3μmol/L。 Objective To study the inhibitory activities of 3-trifluoromethyl benzamide derivatives against the entry of H5N1 influenza viruses. Methods The lead compound was structurally modified to obtain 3 compounds with inhibitory activities against H5N1 influenza viruses. Specs compound librany was screened and 4 compounds were identified to have such inhibitory activities. The inhibitory activities of these compounds were tested at a celluar level against H5N1 influenza viruses. Results and Conclusion The compounds 1a, 1b, 1e and 1f showed signifcant inhibitory activities against the entry of A/AnHui/1/2005 pseudovirus into the target cells with an IC50 value of 4.7±0.3μmol/L.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2014年第7期961-964,共4页 Journal of Southern Medical University
基金 国家自然科学基金(81373263 U1301224) 广东省自然科学基金(S2012040007938) 高等学校博士学科点专项科研基金(新教师类)(20124433120023) 广东省医学科研基金(B2011189)~~
关键词 H5N1禽流感病毒 流感病毒进入抑制剂 血凝素 苯甲酰胺 H5N1 avian influenza virus influenze virus entry inhibitor hemagglutinin benzamide
  • 相关文献

参考文献15

  • 1Morens DM,Fauci AS. The 1918 influenza pandemic:insights for the 21st century[J].Journal of Infectious Diseases,2007,(07):1018-1028.
  • 2Kobasa D,Jones SM,Shinya K. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus[J].NATURE,2007,(7125):319-323.
  • 3Weinstock DM,Zuccotti G. Adamantane resistance in influenza A[J].JAMA:the Journal of the American Medical Association,2006,(08):934-936.
  • 4Saito R,Li D,Suzuki H. Amantadine-resistant influenza A(H3N2) virus in Japan,2005-2006[J].New England Journal of Medicine,2007,(03):312-313.
  • 5Rameix-Welti MA,Agou F,Buchy P. Natural variation can significantly alter the sensitivity of influenza A(H5N1)viruses to oseltamivir[J].Antimicrobial Agents and Chemotherapy,2006,(11):3809-3815.
  • 6Vanderlinden E,G?ktas F,Cesur Z. Novel inhibitors of influenza virus fusion:structure-activity relationship and interaction with the viral hemagglutinin[J].Journal of Virology,2010,(09):4277-4288.
  • 7Song JM,Park KD,Lee KH. Biolog ical evaluation of an ti in fluenza viral activity of sem i synthetic catechin d erivatives[J].Antiviral Research,2007,(02):178-185.
  • 8Cianci C,Yu KL,Dischino DD. pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion[J].Journal of Virology,1999,(03):1785-1794.
  • 9Staschke KA,Hatch SD,Tang JC. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid[J].Journal of Virology,1998,(02):264-274.
  • 10Tang GZ,Lin XF,Qiu ZX. Design and synthesis of benzenesulfonamide derivatives as potent Anti-Influenza hemagglutinin inhibitors[J].ACS Med Chem Lett,2011,(08):603-607.

同被引文献28

  • 1陈璐儿,庄忻雨,张桐,孙世宇,汪伟,曾博宇,于潼,鲁会军,田明尧,金宁一.重组H5N1亚型流感病毒铁蛋白纳米粒mRNA疫苗的构建、表达及鉴定[J].中国病原生物学杂志,2021,16(11):1244-1248. 被引量:1
  • 2刘颂,王京燕.抗流感病毒药物的研究进展[J].国外医学(药学分册),2005,32(2):111-115. 被引量:33
  • 3金冬雁.甲型流感病毒H5N1的系统进化分析简评[J].病毒学报,2007,23(3):240-243. 被引量:3
  • 4Schade D,Kotthaus J, Riebling L, et al. Development of novelpotent orally bioavailable oseltamivir derivatives active againstresistant influenza A[J]. J Med Chem, 2014,57(3): 759-69.
  • 5Liu S, Li R,Zhang R, et al. CL-385319 inhibits H5N1 avianinfluenza A virus infection by blocking viral entry [J]. Eur JPharmacol, 2011,660(2/3): 460-7.
  • 6An J, Lee DC, Law AH, et al. A novel small-molecule inhibitor ofthe avian influenza H5N1 virus determined through computationalscreening against the neuraminidase[J]. J Med Chem, 2009, 52(9):2667-72.
  • 7Neumann G, Noda T,Kawaoka Y. Emergence and pandemicpotential of swine-origin H1N1 influenza virus [J]. Nature, 2009,459(7249): 931-9.
  • 8Hsieh HP,Hsu JT. Strategies of development of antiviral agentsdirected against influenza virus replication [J]. Curr Pharm Des,2007,13(34): 3531-42.
  • 9Zhu Z, Li R, Xiao G, et al. Design, synthesis and structure-activityrelationship of novel inhibitors against H5N1 hemagglutinin-mediated membrane fusion[j]. Eur J Med Chem, 2012,57: 211-6.
  • 10Pinto LH, Holsinger LJ, Lamb RA. Influenza virus M2 protein hasion Channel activity[j]. Cell, 1992, 69(3): 517-28.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部